These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31988837)

  • 1. Exploring genetic targets of psoriasis using genome wide association studies (GWAS) for drug repurposing.
    Nanda H; Ponnusamy N; Odumpatta R; Jeyakanthan J; Mohanapriya A
    3 Biotech; 2020 Feb; 10(2):43. PubMed ID: 31988837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New "drugs and targets" in the GWAS era of bipolar disorder.
    Qi HX; Xiao X; Li T; Li M
    Bipolar Disord; 2023 Aug; 25(5):410-421. PubMed ID: 36633396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enlightenment from genome-wide association study to genetics of psoriasis].
    ZHANG XJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):333-7. PubMed ID: 19693967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Druggable cancer secretome: neoplasm-associated traits.
    Narayanan R
    Cancer Genomics Proteomics; 2015; 12(3):119-31. PubMed ID: 25977171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of genomic variants to drive drug repurposing for chronic hepatitis B.
    Irham LM; Adikusuma W; Perwitasari DA; Dania H; Maliza R; Faridah IN; Santri IN; Phiri YVA; Chong R
    Biochem Biophys Rep; 2022 Sep; 31():101307. PubMed ID: 35832745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Drug Repurposing for Alzheimer's Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies.
    Xu Y; Kong J; Hu P
    Front Pharmacol; 2021; 12():617537. PubMed ID: 34276354
    [No Abstract]   [Full Text] [Related]  

  • 7. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
    Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP
    BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Shared Mechanism and Candidate Drugs of Multiple Sclerosis and Sjögren's Syndrome Analyzed by Bioinformatics Based on GWAS and Transcriptome Data.
    Hong X; Wang X; Rang X; Yin X; Zhang X; Wang R; Wang D; Zhao T; Fu J
    Front Immunol; 2022; 13():857014. PubMed ID: 35356004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function.
    Reay WR; El Shair SI; Geaghan MP; Riveros C; Holliday EG; McEvoy MA; Hancock S; Peel R; Scott RJ; Attia JR; Cairns MJ
    Elife; 2021 Mar; 10():. PubMed ID: 33720009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Novel Psoriatic Disease Drug Targets Using a Genetics-Based Priority Index Pipeline.
    Bui A; Liu J; Hong J; Hadeler E; Mosca M; Brownstone N; Liao W
    J Psoriasis Psoriatic Arthritis; 2021 Oct; 6(4):185-197. PubMed ID: 35756599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.
    Uimari O; Rahmioglu N; Nyholt DR; Vincent K; Missmer SA; Becker C; Morris AP; Montgomery GW; Zondervan KT
    Hum Reprod; 2017 Apr; 32(4):780-793. PubMed ID: 28333195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GWAS and drug targets.
    Cao C; Moult J
    BMC Genomics; 2014; 15 Suppl 4(Suppl 4):S5. PubMed ID: 25057111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics.
    Lam M; Chen CY; Ge T; Xia Y; Hill DW; Trampush JW; Yu J; Knowles E; Davies G; Stahl EA; Huckins L; Liewald DC; Djurovic S; Melle I; Christoforou A; Reinvang I; DeRosse P; Lundervold AJ; Steen VM; Espeseth T; Räikkönen K; Widen E; Palotie A; Eriksson JG; Giegling I; Konte B; Hartmann AM; Roussos P; Giakoumaki S; Burdick KE; Payton A; Ollier W; Chiba-Falek O; Koltai DC; Need AC; Cirulli ET; Voineskos AN; Stefanis NC; Avramopoulos D; Hatzimanolis A; Smyrnis N; Bilder RM; Freimer NB; Cannon TD; London E; Poldrack RA; Sabb FW; Congdon E; Conley ED; Scult MA; Dickinson D; Straub RE; Donohoe G; Morris D; Corvin A; Gill M; Hariri AR; Weinberger DR; Pendleton N; Bitsios P; Rujescu D; Lahti J; Le Hellard S; Keller MC; Andreassen OA; Deary IJ; Glahn DC; Huang H; Liu C; Malhotra AK; Lencz T
    Neuropsychopharmacology; 2021 Sep; 46(10):1788-1801. PubMed ID: 34035472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates.
    Lalagkas PN; Melamed RD
    Res Sq; 2024 Jun; ():. PubMed ID: 38947022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of comorbidity target pools and prediction of drugs candidate for multiple sclerosis and autoimmune thyroid diseases based on GWAS and transcriptome data.
    Wang X; Wang Y; Zhang X; Hong X; Rang X; Yang D; Huang S; Xu C; Fu J
    Mult Scler Relat Disord; 2023 Oct; 78():104903. PubMed ID: 37556937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Genetic Basis of Psoriasis.
    Capon F
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.
    Fang J; Zhang P; Wang Q; Chiang CW; Zhou Y; Hou Y; Xu J; Chen R; Zhang B; Lewis SJ; Leverenz JB; Pieper AA; Li B; Li L; Cummings J; Cheng F
    Alzheimers Res Ther; 2022 Jan; 14(1):7. PubMed ID: 35012639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic.
    Lencz T; Malhotra AK
    Mol Psychiatry; 2015 Jul; 20(7):820-6. PubMed ID: 25869805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.
    Aterido A; Cañete JD; Tornero J; Ferrándiz C; Pinto JA; Gratacós J; Queiró R; Montilla C; Torre-Alonso JC; Pérez-Venegas JJ; Fernández Nebro A; Muñoz-Fernández S; González CM; Roig D; Zarco P; Erra A; Rodríguez J; Castañeda S; Rubio E; Salvador G; Díaz-Torné C; Blanco R; Willisch Domínguez A; Mosquera JA; Vela P; Sánchez-Fernández SA; Corominas H; Ramírez J; de la Cueva P; Fonseca E; Fernández E; Puig L; Dauden E; Sánchez-Carazo JL; López-Estebaranz JL; Moreno D; Vanaclocha F; Herrera E; Blanco F; Fernández-Gutiérrez B; González A; Pérez-García C; Alperi-López M; Olivé Marques A; Martínez-Taboada V; González-Álvaro I; Sanmartí R; Tomás Roura C; García-Montero AC; Bonàs-Guarch S; Mercader JM; Torrents D; Codó L; Gelpí JL; López-Corbeto M; Pluma A; López-Lasanta M; Tortosa R; Palau N; Absher D; Myers R; Marsal S; Julià A
    Ann Rheum Dis; 2019 Mar; 78(3):. PubMed ID: 30552173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.